Internal and external stakeholder alignment and engagement in support of multiple HTA submissions

Internal and external stakeholder alignment and engagement in support of multiple HTA submissions

Andrew Butcher
Life Sciences

Situation

 

  • UK affiliate of global pharma company
  • Inconsistent views on positioning between medical and commercial
  • Need for coordination and engagement of key stakeholders
  • Tactical support required

Actions

 

  • Development of value proposition across cross-functional group to support HTA submissions and external engagement, across:
    • Clinical
    • Medical affairs
    • Commercial
    • Key affiliates
  • Facilitated cross functional steering group to plan and drive program
  • Planned and chaired multi-disciplinary advisory board
  • Managed relations with Patient advocacy groups
  • Co-ordinated plan with external relations teams

Results

 

  • Internal buy-in and alignment
  • Program delivered in a coordinated fashion
  • Impactful relationships generated with key stakeholders
  • High profile media coverage
  • Favourable outcomes for HTAs